(Circulation. 1997;96:308-315.)
© 1997 American Heart Association, Inc.
Articles |
Hemodynamic Patterns of Age-Related Changes in Blood Pressure
The Framingham Heart Study
From the Heart Disease Prevention Program, University of California, Irvine (S.S.F, W.G., N.D.W.); the Framingham Heart Study, Framingham, Mass (M.G.L., W.B.K., D.L.); The National Heart, Lung and Blood Institute, Bethesda, Md (D.L.); and Brookdale Hospital Medical Center, Brooklyn, NY (M.A.W.).
Correspondence to Dr Franklin, UCI Heart Disease Prevention Program, C240 Medical Sciences, University of California Irvine, Irvine, CA 92697.
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Background We attempted to characterize age-related changes in blood pressure in both normotensive and untreated hypertensive subjects in a population-based cohort from the original Framingham Heart Study and to infer underlying hemodynamic mechanisms.
Methods and Results A total of 2036 participants were divided into four groups according to their systolic blood pressure (SBP) at biennial examination 10, 11, or 12. After excluding subjects receiving antihypertensive drug therapy, up to 30 years of data on normotensive and untreated hypertensive subjects from biennial examinations 2 through 16 were used. Regressions of blood pressure versus age within individual subjects produced slope and curvature estimates that were compared with the use of ANOVA among the four SBP groups. There was a linear rise in SBP from age 30 through 84 years and concurrent increases in diastolic blood pressure (DBP) and mean arterial pressure (MAP); after age 50 to 60 years, DBP declined, pulse pressure (PP) rose steeply, and MAP reached an asymptote. Neither the fall in DBP nor the rise in PP was influenced significantly by removal of subsequent deaths and subjects with nonfatal myocardial infarction or heart failure. Age-related linear increases in SBP, PP, and MAP, as well as the early rise and late fall in DBP, were greatest for subjects with the highest baseline SBP; this represents a divergent rather than parallel tracking pattern.
Conclusions The late fall in DBP after age 60 years, associated with a continual rise in SBP, cannot be explained by "burned out" diastolic hypertension or by "selective survivorship" but is consistent with increased large artery stiffness. Higher SBP, left untreated, may accelerate large artery stiffness and thus perpetuate a vicious cycle.
Key Words: blood pressure • hypertension • aging • epidemiology • physiology
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
There is a progressive increase in blood pressure with aging in industrialized societies, beginning in childhood and continuing into adulthood.1 2 3 4 This trend is associated with a greater increase in SBP than DBP during the middle adult years. Whereas SBP continues to rise until the eighth or ninth decade, DBP tends to remain constant or decline after the fifth or sixth decade; as a consequence, PP increases progressively with age and the rate of rise accelerates after age 50 years. There also is a sex difference in blood pressure trends; women's blood pressure starts lower than men's, catches up by the sixth decade, and frequently becomes slightly higher thereafter. The majority of studies demonstrating age-related blood pressure changes in populations have been cross-sectional4 ; however, two longitudinal studies have reported the same pattern.1 3
What remains unclear, however, are the hemodynamic factors responsible for the age-related changes in blood pressure. The Framingham Heart Study provides a unique opportunity to observe the effects of aging on untreated blood pressure in a population-based cohort. This study began in 1948, long before the efficacy of treating mild and moderate hypertension had been established; only a minority of hypertensive participants of the original Framingham cohort were receiving antihypertensive therapy until the 1980s,5 and these treated subjects were excluded from our analysis.
Previous Framingham publications have emphasized the increase in prevalence of hypertension with advancing age and the predominance of systolic hypertension in the elderly.6 7 The goals of the present investigation were (1) to identify, in both normotensive and untreated hypertensive subjects, age-related changes in SBP, DBP, PP, and MAP, and (2) to infer alterations in hemodynamics based on longitudinal changes in blood pressure components.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Overview
The Framingham Heart Study began in 1948 with the enrollment of 5209 men and women, 28 to 62 years of age at entry, with all subjects undergoing biennial examinations. Each examination included an extensive cardiovascular history and physical examination, 12-lead ECG, and various blood chemistries. Morbidity and mortality were continuously monitored by biennial clinic examinations and by communication with physicians and relatives. All new cardiovascular events were reviewed by a panel of three experienced investigators. Detailed descriptions of study design and of end points for coronary heart disease have been published elsewhere.8 9 10
Study Population
The sample analyzed for this report included individuals
who had Framingham measurements of HDL cholesterol as part
of a complete lipid profile and also had no clinical evidence of
coronary heart disease. The earliest available examination at
which HDL cholesterol was measured served as the index
examination for each subject; usually this was the 11th biennial
examination but for some it was the 10th or 12th. These subjects have
been investigated in an ongoing follow-up study. In addition, the
population studied in the present investigation met the following
criteria: (1) all participants were between the ages of 50 and 79 years
at the index examination; (2) they were not receiving antihypertensive
medication at baseline or before baseline; and (3) they had four or
more examinations (from examinations 2 through 16) at which untreated
blood pressure levels were measured. The mean number of biennial
measurements of untreated blood pressure per subject was 12.3.
Of the original 5209 cohort participants, 780 died before the index examination, 676 did not attend a biennial examination during the prescribed period, and 877 did not receive a full lipid profile. Also excluded were 329 subjects because of clinically apparent coronary disease, 335 for receiving antihypertensive therapy, 95 for loss to follow-up, 48 because of insufficient data collection, and 33 because of age exclusion (<50 or >79 years).
Blood Pressure Measurement
Readings of SBP and DBP were taken in the supported left arm of
the seated subject with the use of a mercury column sphygmomanometer
with cuff-size adjustment made on the basis of arm circumference.
Readings were recorded to the nearest even number. The SBP was
recorded at the first appearance of Korotkoff sounds, and the
palpitatory method was used to check auscultatory systolic
readings. The DBP was recorded at the disappearance (phase V) of
Korotkoff sounds. Determinations of SBP and DBP were based on the
average of two separate measurements taken by the examining physician
at each examination; however, if only one reading was recorded, its
value was used.
Data Analysis
The sample used in this study consisted of 2036 subjects
(890 men and 1146 women). These individuals were then divided into four
groups (Table 1
) according to recorded SBP at the index
examination: group 1, <120 mm Hg; group 2, 120 to 139
mm Hg; group 3, 140 to 159 mm Hg; and group 4, 
160
mm Hg. By use of the new classification of
hypertension, based on the Joint National Committee on Detection,
Evaluation, and Treatment of High Blood Pressure (JNC V), group 1
consisted of "optimal" SBP; group 2, normal and high normal SBP;
group 3, stage 1 systolic hypertension; and group 4, stages 2,
3, and 4 systolic hypertension.11 SBP, DBP, PP,
and MAP were obtained from biennial examinations 2 (antecedent) to 16
(subsequent). PP was defined as PP=SBP-DBP, and MAP was calculated
from the standard equation MAP=(2/3)DBP+(1/3)SBP (in
mm Hg). Values from the first biennial examination were not used
because both SBP and DBP on that examination were generally higher than
recorded on subsequent examinations. This finding was
consistent with regression to the mean or a first-visit
"white coat" hypertensive effect.
|
In the analysis of selected clinical characteristics by SBP
groups, the 
2 test was used to compare
distributions of categorical variables. ANCOVA, after adjustment of
baseline data for age, was used to compare means of continuous
variables.
Initially, to provide an overview of arterial pressure relations with age, all available data within each given age interval (ages 30 to 34 through 80 to 84) on each arterial pressure component were averaged, by index examination SBP groupings from biennial examinations 2 to 16, as available, for all subjects. Thus, each subject contributed up to 15 examinations with blood pressure values recorded before and after the index examination. These analyses of group averaged data were conducted for the entire study cohort and again after excluding post–index examination deaths and subjects with nonfatal MI or CHF to evaluate for effects of possible "selective survivorship."
To determine if age-related patterns in blood pressure slope or curvature differed by SBP groupings, least-squares regression equations12 were obtained for each subject, with the use of linear and quadratic terms for age, adjusted to an intercept estimated at age 60 years. One-way ANOVA13 was used to compare means of slopes and curvatures among SBP groupings. These analyses were done for the entire cohort, separately for men and women. SAS statistical software (SAS Institute, Cary, NC)14 was used. A value of P<.01 was considered significant.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
The SBP groupings of normotensive and untreated hypertensive subjects with various clinical characteristics are detailed and compared in Table 1
. On the basis of index examination SBP values, 37%
of subjects had hypertension (groups 3 and 4), 41% had normal or high
normal blood pressure (group 2), and 22% had optimal blood pressure
(group 1). Groups 3 and 4 were composed of 61% isolated
systolic hypertension as defined by DBP <90 mm Hg and
SBP 140 mm Hg; 39% had combined
systolic-diastolic hypertension as defined by DBP
90 mm Hg and SBP 140 mm Hg. Approximately one third of
subjects with isolated systolic hypertension had a DBP
90 mm Hg at any examination before their index examination.
Women made up 62% of subjects with isolated systolic
hypertension and 47% of those with combined
systolic-diastolic hypertension. As expected, there
was a direct correlation between SBP groupings and BMI, diabetes
mellitus, left ventricular hypertrophy by ECG,
claudication, and stroke. There were no clinically significant
correlations between body height, total cholesterol, and
SBP groupings. Smoking was inversely related to both SBP groupings and
BMI.
Group Averages
Arterial pressure components by age,
representing group averages, are shown in Fig 1 (thick
line) for all available data from each subject classified into 5-year
age intervals (30 to 34 through 80 to 84) and classified by index
examination SBP groups 1 through 4. The SBP
patterns showed a consistent linear rise with aging in all four
groups. The DBP patterns showed a significant early rise and late fall
with a transition around age 50 to 60 years. Both normotensive subjects
(groups 1 and 2) and hypertensive subjects (groups 3 and 4) displayed
this early rise and late fall in the DBP. The PP showed a small early
rise and an accelerated late rise in all groups. Since PP is increased
by bradycardia, heart rates were compared within and between groups.
There was a significant increase in heart rate, after sex and age
correction, in SBP groups 1 through 4; the values were 72.7, 75.0,
77.5, and 80.5 bpm, respectively (P=.0001). In contrast,
there were no significant changes in heart rates within SBP groups from
the fourth to the ninth decades. Examination of the MAP pattern showed
an early linear rise peaking around age 50 or 60 years, with groups 3
and 4 showing a small decline by the seventh to ninth decades. When 683
post–index examination deaths and subjects with nonfatal acute MI or
CHF were excluded, a reanalysis of the remaining 1353 subjects
showed essentially unchanged patterns for all four arterial
components including the rise and fall in DBP (Fig 1, thin line).
|
Sex Differences
Fig 2 shows group averaged data by sex for groups 1 and 4 for
comparison of differences between the highest and lowest SBP
groupings. There was a lower SBP in women
than in men at the fourth decade by 13 to 14 mm Hg in group 4 and
3 to 4 mm Hg in group 1; this sex difference gradually narrowed
and disappeared by the end of the seventh decade and reversed by the
eighth decade, with women having a 4 to 5 mm Hg greater SBP than
men in both groups 4 and 1. For DBP, group 4 women had an 8 to 9
mm Hg and group 1 women had a 2 to 3 mm Hg lower value than men
in the fourth decade; these differences disappeared by the end of the
seventh decade. Women had a slightly lower PP than men in the fourth
decade by 4 to 5 mm Hg in group 4 but no difference in group 1;
this sex difference gradually narrowed and then reversed by the seventh
decade. By the ninth decade, women had a 6 to 7 mm Hg greater PP
than men in group 4 and a 2 to 3 mm Hg greater PP in group 1
subjects. Women had a lower MAP than men in the fourth decade by 10 to
11 mm Hg in group 4 and a 3 to 4 mm Hg difference in group
1; this sex difference gradually narrowed and disappeared by the end of
the seventh decade.
|
Individual Regression Analysis
Intergroup comparisons of slopes and curvatures for
arterial pressure components by age and sex from ANOVA are
shown in Table 2. Fig 3 presents plots of
smoothed blood pressure variables by index SBP groups derived from
the coefficients in Table 2. SBP slopes
increased significantly from group 1 to group 4 (F=34.1,
P<.001) and differed significantly between all SBP group
pairings (P<.001) with the exception of group 1 versus
group 2 (not significant). Curvature coefficients for SBP were small,
and there were few significant differences among groups, indicating
that the association of SBP with age was linear. DBP curvatures but not
slopes showed a significant increase across index examination SBP
groupings in pooled sex analysis (F=5.5,
P<.001); in addition, there were significant differences in
curvature between normotensive groups 1 and 2 and hypertensive groups 3
and 4 (P<.01) except between group 2 and group 4
(P=.07). Comparisons of PP slopes showed an increase by SBP
groups (F=38.8, P<.001), with highly significant
differences (P<.001) between nearly all group pairings; PP
curvatures differed much less among groups. Comparisons of the MAP
slopes showed a significant increase across all four groups
(F=16.3, P<.01) and between all group pairs
(P<.01), with the exception of group 1 versus group 2 (NS);
MAP curvatures differed to a lesser extent.
|
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
The normotensive and untreated hypertensive subjects in this study showed a linear rise in SBP from age 30 through 84 years and a concurrent early increase in DBP and MAP; after age 50 to 60 years, DBP declined, PP rose steeply, and MAP reached an asymptote. Analysis of individual subject regressions as a function of index examination SBP groups showed that linear slopes differed for SBP, PP, and MAP, whereas it was curvature that differed for DBP; these represented divergent rather than parallel tracking patterns.
The age-related late fall in DBP, as noted in previous cross-sectional studies and in the present investigation, has not been adequately explained. The reduction of DBP after age 60 years has been attributed to "burned out" diastolic hypertension,15 but this decrease in DBP was observed in both normotensive and untreated hypertensive individuals, making it unlikely that "burned out" diastolic hypertension could explain the decreasing DBP in the elderly. Furthermore, only about one third of subjects with isolated systolic hypertension in groups 3 and 4 had an elevated DBP at an examination before the index visit. Similarly, the concept of "selective survivorship," whereby vulnerable patients are eliminated because of premature death, has been postulated as a cause of the late decline in DBP. Again, when all deaths and patients with nonfatal MI or CHF were removed from the study sample, the late fall in DBP was still present, making "selective survivorship" an unlikely explanation. A further hypothesis, namely an age-related decrease in cardiac output as the cause for the late fall in DBP, is inconsistent with the late rise in SBP. The most likely explanation, therefore, for the fall in DBP after age 60 years is increased large artery stiffness.16 17 18 19 20 21
The decline in DBP seen in the elderly is probably the result rather than the cause of the disease process. Age-related stiffening of the aorta is associated with a decreased capacity of the elastic reservoir and hence a greater peripheral runoff of stroke volume during systole. Thus, with less blood remaining in the aorta at the beginning of diastole, and with diminished elastic recoil, diastolic pressure decreases with increased steepness of diastolic decay.22 The exaggerated fall in DBP seen in elderly hypertensive subjects suggests a process of transmural pressure-induced arterial wall damage resulting in large artery stiffness.16 23
The steep rise in PP after the sixth decade, in part secondary to the fall in DBP, cannot be due to elevated cardiac output or bradycardia, since studies in elderly hypertensives have shown a reduction in cardiac output at rest,24 25 and we found a significant stepwise increase in heart rate with rising SBP in the present analysis. The rise in heart rate, as noted in SBP groups 1 through 4, would decrease rather than increase PP. The most plausible explanation for both the late rise in PP and the fall in DBP is an increase in large artery stiffness caused by intrinsic structural abnormalities. The pathological processes of thinning, fragmentation, and eventual fracturing of elastin and increased collagen and calcium deposition in the large arteries are likely explanations.18 26 27 28
Calculated MAP is used commonly as an approximation of vascular
resistance when cardiac output is not elevated.19 20
However, the leveling off of MAP after age 50 to 60 years in all SBP
groups in the present study suggests that vascular resistance is
underestimated in older persons, since there is firm evidence that
vascular resistance continues to rise with aging.24 29 30 31 32
True vascular resistance is underestimated by the MAP equation in part
because aging alters the pulse wave contour, such that the standard
form factor of 0.33 becomes closer to 0.5 (a sign-wave
pattern).18 In addition, if the rate of fall in DBP is
substantial, as seen in hypertensive SBP groups 3 and 4, the calculated
MAP actually decreases after the seventh or eighth decade (Fig 1),
further contributing to underestimation of vascular resistance.
Clearly, after age 50 years, the MAP equation is no longer a surrogate
measurement for vascular resistance.
The present study supports the concept of an interaction between
aging and hypertension in the progressive fall of DBP and rise of SBP.
Group 1, with the lowest index SBP, had no early rise in PP and only a
minimal early increase in MAP with age (Fig 1). Nevertheless, group 1
showed a significant rise in PP and fall in DBP after age 60 years,
presumably caused by an increase in large artery stiffness secondary to
aging in these initially normotensive subjects (mean index blood
pressure of 111/70). In contrast, group 4, with high baseline SBP (mean
index blood pressure of 173/90), showed both a significantly steeper
rise in PP and a fall in DBP after age 60 than was observed in group 1
subjects. These findings suggest a linkage between hypertension left
untreated and subsequent late acceleration of large artery stiffness.
This in turn may perpetuate a vicious cycle of accelerated rise in SBP
and a further increase in large artery stiffness.
Age-related blood pressure changes were generally similar in both sexes, but as noted in previous studies, young women had lower blood pressure values than similarly aged men; these differences gradually narrowed and eventually reversed beyond age 60 years. The lower blood pressure in young women compared with young men has been explained by their shorter stature; blood pressure amplification from central to peripheral arteries increases with body height and is therefore more marked in men.33 Sex differences in blood pressure were more marked in hypertensive subjects. These findings suggest that there may be sex differences in arterial stiffening, with young women having more compliant vessels. With the onset of menopause this difference may be lost, with a resulting acceleration in arterial stiffening.34 35
Alterations in hemodynamics, in the absence of direct measurements, can be inferred by means of longitudinal changes in blood pressure variables as assessed in the present study. Arterial pressure can be divided into steady (MAP) and pulsatile components (PP).16 17 18 19 MAP is determined by cardiac output and vascular resistance. The PP component, representing the variation in pressure around the mean, is influenced by left ventricular ejection, large artery stiffness, early pulse wave reflection, and heart rate. Both increased resistance and increased stiffness elevate SBP. In contrast, DBP rises with increased resistance but falls with increased stiffness; the relative contribution of each determines the ultimate DBP.16 17 18 19 20 21 Therefore, age-related changes in SBP and DBP may predict the relative contributions of vascular resistance and large artery stiffness.
The hemodynamic significance of the rises in MAP, SBP, and DBP from age 30 to 49 years in the present study is consistent with a gradual increase in peripheral vascular resistance with aging.19 Increased cardiac output appears to produce similar changes in these arterial pressure components. However, the transitory increase in cardiac output observed in some hypertensive young adults reverts over time into a persistent increase in vascular resistance.36 Therefore, the slowly progressive increases in MAP, SBP, and DBP, noted in both normotensive and untreated hypertensive Framingham subjects from age 30 to 49, most likely result from increased peripheral vascular resistance.
The pulsatile component of arterial pressure (PP) varies
with age. During the fourth and fifth decades we found that the
increase in PP was small and correlated with the rise in MAP in groups
1 through 4 (Fig 1). This could be explained by a "downstream"
increase in vascular resistance causing an "upstream" increase in
transmural pressure, which in turn chronically stretched large central
arteries and increased their stiffness.
There is strong evidence that vascular resistance is not the dominant factor in the rise in SBP after age 60 years. While measurements of cardiac output and blood pressure suggest increased vascular resistance with aging,29 30 total peripheral resistance is only marginally elevated in older subjects with isolated systolic hypertension compared with age- and sex-matched normotensive control subjects.24 31 Furthermore, studies of elderly subjects with isolated systolic hypertension showed that increased input impedance (large artery stiffness and early pulse wave reflection) predominated over increased vascular resistance.32 In addition, a computer simulation of a modified Windkessel model for geriatric isolated systolic hypertension indicated that vascular resistance increased by only 25%, whereas there was a 50% to 75% increase in input impedance secondary to large artery stiffness and early wave reflection.37 These conclusions are further supported by the observed decrease in DBP and increase in SBP after age 60 in the Framingham subjects.
The age-related linear rise in SBP from age 30 to 84 years, coupled with an early rise and late fall in DBP, suggests three hemodynamic phases. Under age 50, the progressive rise in DBP suggests the predominance of increased vascular resistance. The constancy of DBP during the 50s, together with the asymptotic leveling of MAP and increased slope of PP, suggests that increased vascular resistance and large artery stiffness are both increasing in a parallel manner. The fall in DBP during the later ages signals a preponderance of large artery stiffness as the cause of further rise in SBP in the elderly.
The strengths of this investigation, compared with previous longitudinal studies of age-related changes in blood pressure,1 3 are the elimination of treated hypertensive subjects from the analysis, the greater number of interval examinations (up to 16 per subject), and the tracking of age-related blood pressure patterns by normotensive and hypertensive SBP groupings.
There are potential limitations in the present study. Since the
original Framingham population consisted of >99% Caucasians, the
majority of whom were middle-class subjects, results may not apply to
other ethnic or socioeconomic groups. The defined population consisted
of subjects with a minimum age of 30 years at entry. Therefore, the
results do not apply to children, adolescents, or young adults.
However, previous longitudinal studies of age-related blood pressure
changes in the young have shown a strong correlation of age with MAP,
SBP, and DBP.38 There may have been a selection bias
resulting from the exclusion of 335 subjects receiving antihypertensive
therapy, which represented 30% of the hypertensive
population in this study. Since elevated DBP was the main criterion for
treating hypertension until the early 1980s, this may have resulted in
a higher prevalence of isolated systolic hypertension in the
present study. However, this selection process, by eliminating the
most severe hypertensives on treatment, resulted in a study of
normotensives and predominantly untreated stage 1 hypertension. The
latter comprises 
74% of hypertensives, as noted in population
studies.39 The conclusions regarding observed differences
in blood pressure patterns with aging may in part be confounded by risk
factors not adjusted for in the present analysis. However,
the intent of this study was to identify age-related blood pressure
changes in a population-based cohort; future studies will address
possible etiologic factors.
Does the presence of pseudohypertension impose limits on the conclusions of this study? With the most careful cuff measurements, true SBP is underestimated by 0 to 5 mm Hg and true DBP overread by 5 to 15 mm Hg or more compared with simultaneous intra-arterial pressure recordings.40 Although the DBP artifact may be present regardless of age or blood pressure level, this entity is found more frequently in elderly hypertensives with large artery stiffness.40 If diastolic pseudohypertension is present and underdiagnosed in the current study, the risk markers of increased PP and decreased DBP would be biased toward the null. We conclude that diastolic pseudohypertension, if present, would lead to an underestimation of true large artery stiffness.
Summary
The early rise in MAP, SBP, and DBP, up to age 50 years, is
consistent with increasing peripheral vascular
resistance. The late fall in DBP after age 50 to 60, associated with a
steep rise in PP, cannot be explained by "burned out"
diastolic hypertension or by "selective survivorship"
but is consistent with increased large artery stiffness. The
linear rise in SBP seen with aging is due primarily to increased
peripheral vascular resistance during the early years and
to increased large artery stiffness during the late years. After age
50, there is a progressive underestimation of vascular resistance by
the MAP equation, largely because of a changing contour in the
arterial pulse wave and the declining DBP. Despite a
probable further increase in vascular resistance with aging, downward
movement in DBP indicates that large artery stiffness predominates.
The most important clinical implications that can be derived from this study are that after the sixth decade of life, (1) increasing PP and decreasing DBP are surrogate measurements for large artery stiffness; (2) large artery stiffness rather than vascular resistance becomes the dominant hemodynamic factor in both normotensive and hypertensive subjects; and (3) hypertension, left untreated, may accelerate the rate of development of large artery stiffness. This, in turn, can perpetuate a vicious cycle of accelerated hypertension and further increases in large artery stiffness. These factors should be considered in cardiovascular risk stratification of the elderly and in selection of treatment modalities.
|
Selected Abbreviations and Acronyms |
|---|
|
|
Acknowledgments |
|---|
This study was supported in part by National Institutes of Health/National Heart, Lung, and Blood Institute contract No. 1-HC-38038 and ASTRA USA Inc Visiting Scientist Program.
Received September 25, 1996; revision received January 2, 1997; accepted January 9, 1997.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Gordon I, Shurtleff D. Section 29. Means at each examination and inter-examination variation of specified characteristics: Framingham Study, Exam 1 to Exam 10. In: Kannel WB, Gordon T, eds. The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease. Washington DC: US Department of Health, Education, and Welfare (National Institutes of Health); 1977:474-478.
2. Kannel WB, Gordon T. Evaluation of cardiovascular risk in the elderly: the Framingham study. Bull N Y Acad Med. 1978;54:573-591.[Medline] [Order article via Infotrieve]
3. Miall WE, Brennan PJ. Hypertension in the elderly: the South Wales Study. In: Onesti G, Kim KE, eds. Hypertension in the Young and Old. 1st ed. New York, NY: Grune & Stratton; 1981:277-283.
4. Whelton PK. Blood pressure in adults and the elderly. In: Bulpitt CJ, ed. Handbook of Hypertension. Vol 6. Amsterdam, Netherlands: Elsevier; 1985:51-69.
5.
Dannenberg AL, Kannel WB. Remission of
hypertension: the `natural' history of blood pressure treatment in
the Framingham Study. JAMA. 1987;257:1477-1483.
6. Wilking SVB, Belanger A, Kannel WB, D'Agostino RB, Steel K. Determinants of isolated systolic hypertension. JAMA. 1988;250:3451-3455.
7.
Sagie A, Larson MG, Levy D. The natural history
of borderline isolated systolic hypertension.
N Engl J Med. 1993;329:1912-1917.
8. Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health. 1951;41:279-286.
9. Dawber TR, Kannel WB, Lyell LP. An approach to longitudinal studies in a community: the Framingham Study. Ann N Y Acad Sci. 1963:107:539-556.
10. Some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements: Framingham Heart Study, 30-year follow-up. In: Kannel WB, Wolf PA, Garrison RJ, eds. The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease. Section 34. Bethesda, Md: National Heart, Lung, and Blood Institute; 1987. DHHS publication No. (NIH) 87-2703.
11.
The Fifth Report of the Joint National Committee on
Detection, Evaluation, and Treatment of High Blood Pressure (JNC V).
Arch Intern Med. 1993;153:154-183.
12. Rosner B. Fitting regression lines: the method of least squares. In: Fundamentals of Biostatistics. Boston, Mass: PWS Kent; 1990:401-404.
13. Rosner B. One-way ANOVA. In: Fundamentals of Biostatistics. Boston, Mass: PWS Kent; 1990:475-480.
14. SAS User's Guide: Statistics, Version 5, 1985. GLM Procedure. Cary, NC: SAS Institute Inc; 1985:433-504.
15. Bulpitt CJ, Palmer AJ, Fletcher AE, Bradley JC, Broxton JS, Davis AJ, Ganvir PL, Gostick NK, Mayhew SR, Mukerji D, Shepherd FS, Wells FO. Proportion of patients with isolated systolic hypertension who have burned-out diastolic hypertension. J Hum Hypertens. 1995;9:675-679.[Medline] [Order article via Infotrieve]
16. O'Rourke MF. Arterial Function in Health and Disease. Edinburgh, UK: Churchill-Livingstone; 1982.
17. Safar ME. Pulse pressure in essential hypertension: clinical and therapeutical implications. J Hypertens. 1989;7:769-776.[Medline] [Order article via Infotrieve]
18. Nichols WW, O'Rourke MF. McDonald's Blood Flow in Arteries. Philadelphia, Pa: Lea & Febiger; 1990.
19. Berne RM, Levy MN. Cardiovascular Physiology. 6th ed. St Louis, Mo: Mosby Year Book. 1992:135-151.
20. Franklin SS, Weber MA. Measuring hypertensive cardiovascular risk: the vascular overload concept. Am Heart J. 1994;128:793-803.[Medline] [Order article via Infotrieve]
21. Franklin SS. The concept of vascular overload in hypertension. Cardiol Clin. 1995;13:501-507.[Medline] [Order article via Infotrieve]
22.
Wiggers CJ. Physical and
physiological aspects of
arteriosclerosis and hypertension.
Ann Intern Med. 1932;6:12-30.
23. Folkow B. Structure and function of the arteries in hypertension. Am Heart J. 1987;114:938-948.[Medline] [Order article via Infotrieve]
24. Messerli FH, Sundgaard-Risse K, Ventura HO, Dunn FG, Glade LB, Frohlich ED. Essential hypertension in the elderly; haemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels. Lancet. 1983;2:983-986.[Medline] [Order article via Infotrieve]
25. Lund-Johansen P, Omvik P. Hemodynamic patterns of untreated hypertensive disease. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. New York, NY: Raven Press Ltd; 1995:323-342.
26. O'Rourke MF, Kelly RP, Avolio AP. The Arterial Pulse. Philadelphia, Pa: Lea & Febiger; 1992.
27. Milch RA. Matrix properties of the aging arterial wall. Monogr Surge Sci.. 1965;2:261-341.
28.
Learoyd BM, Taylor MG. Alterations with age in
the viscoelastic properties of human arterial
walls. Circ Res. 1966;18:278-292.
29. Adamopoulos PN, Chrysanthakopoulis SG, Frohlich ED. Systolic hypertension: nonhomogeneous diseases. Am J Cardiol. 1975;36:697-701.[Medline] [Order article via Infotrieve]
30.
Vardan S, Mookherjee S, Warner R, Smolyan H.
Systolic hypertension in the elderly:
hemodynamic response to long-term thiazide
diuretic therapy and its side effects. JAMA. 1983;250:2807-2813.
31. Terasawa F, Kuramoto K, Ying LH, Suzuki T, Kuramochi M. The study of hemodynamics in older hypertensive subjects. Acta Gerontol Jpn. 1972;56:47-52.
32. Nichols WW, Nicolini FA, Pepine CJ. Determinants of isolated systolic hypertension in the elderly. J Hypertens. 1991;10(suppl 6):S73-S77.
33.
London GM, Guerin AP, Pannier BM, Marchais SJ, Stimpel
M. Influence of sex on arterial
hemodynamics and blood pressure: role of body
height. Hypertension. 1995;26:514-519.
34. Gangar KF, Vyas S, Whitehead M, Crook D, Meire H, Campbell S. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet. 1991;338:839-842.[Medline] [Order article via Infotrieve]
35. Penotti M, Nencioni T, Gabrielli L, Massimiliano F, Castiglioni E, Polvani F. Blood flow variations in internal carotid and middle cerebral arteries induced by post-menopausal hormone replacement therapy. Am J Obstet Gynecol. 1993;169:1226-1232.[Medline] [Order article via Infotrieve]
36. Lund-Johansen P. Twenty-year follow-up of hemodynamics in essential hypertension during rest and exercise. Hypertension. 1991;18(suppl III):III-54-III-61.
37. Berger DS, Li JK. Concurrent compliance reduction and increased peripheral resistance in the manifestation of isolated systolic hypertension. Am J Cardiol. 1990;66:67-71.
38. Rose GA. Hypertension in the community. In: Bulpitt CJ, ed. Handbook of Hypertension. Vol 6, Epidemiology of Hypertension. Amsterdam, Netherlands: Elsevier; 1995:1-14.
39. Neaton JD, Kuller L, Stamler J, Wentworth DN. Impact of systolic and diastolic blood pressure on cardiovascular mortality. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management. New York, NY: Raven Press, Ltd; 1995:127-144.
40. Zweifler AJ, Shahab ST. Pseudohypertension: a new assessment. J Hypertens. 1993;11:1-6.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  E. C. Hart, M. J. Joyner, B. G. Wallin, C. P. Johnson, T. B. Curry, J. H. Eisenach, and N. Charkoudian Age-Related Differences in the Sympathetic-Hemodynamic Balance in Men Hypertension, July 1, 2009; 54(1): 127 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Namasivayam, B. J. McDonnell, C. M. McEniery, M. F. O'Rourke, and on behalf of the Anglo-Cardiff Collaborative Trial Does Wave Reflection Dominate Age-Related Change in Aortic Blood Pressure Across the Human Life Span? Hypertension, June 1, 2009; 53(6): 979 - 985. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Miura, H. Nakagawa, Y. Ohashi, A. Harada, M. Taguri, T. Kushiro, A. Takahashi, M. Nishinaga, H. Soejima, H. Ueshima, et al. Four Blood Pressure Indexes and the Risk of Stroke and Myocardial Infarction in Japanese Men and Women: A Meta-Analysis of 16 Cohort Studies Circulation, April 14, 2009; 119(14): 1892 - 1898. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Chirinos, S. S. Franklin, R. R. Townsend, and L. Raij Body Mass Index and Hypertension Hemodynamic Subtypes in the Adult US Population Arch Intern Med, March 23, 2009; 169(6): 580 - 586. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. McEniery, B. J. McDonnell, A. So, S. Aitken, C. E. Bolton, M. Munnery, S. S. Hickson, Yasmin, K. M. Maki-Petaja, J. R. Cockcroft, et al. Aortic Calcification Is Associated With Aortic Stiffness and Isolated Systolic Hypertension in Healthy Individuals Hypertension, March 1, 2009; 53(3): 524 - 531. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. J. Ekundayo, R. M. Allman, P. W. Sanders, I. Aban, T. E. Love, D. Arnett, and A. Ahmed Isolated Systolic Hypertension and Incident Heart Failure in Older Adults: A Propensity-Matched Study Hypertension, March 1, 2009; 53(3): 458 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Williams The aorta and resistant hypertension. J. Am. Coll. Cardiol., February 3, 2009; 53(5): 452 - 454. [Full Text] [PDF]
|
|
|
|
|
|
S. S. Franklin, V. A. Lopez, N. D. Wong, G. F. Mitchell, M. G. Larson, R. S. Vasan, and D. Levy Single Versus Combined Blood Pressure Components and Risk for Cardiovascular Disease: The Framingham Heart Study Circulation, January 20, 2009; 119(2): 243 - 250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Lieb, M. G. Larson, E. J. Benjamin, X. Yin, G. H. Tofler, J. Selhub, P. F. Jacques, T. J. Wang, J. A. Vita, D. Levy, et al. Multimarker Approach to Evaluate Correlates of Vascular Stiffness: The Framingham Heart Study Circulation, January 6, 2009; 119(1): 37 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. H.G. Henskens, A. A. Kroon, R. J. van Oostenbrugge, E. H.B.M. Gronenschild, M. M.J.J. Fuss-Lejeune, P. A.M. Hofman, J. Lodder, and P. W. de Leeuw Increased Aortic Pulse Wave Velocity Is Associated With Silent Cerebral Small-Vessel Disease in Hypertensive Patients Hypertension, December 1, 2008; 52(6): 1120 - 1126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Rosenfield and M. R. Jaff An 82-Year-Old Woman With Worsening Hypertension: Review of Renal Artery Stenosis JAMA, November 5, 2008; 300(17): 2036 - 2044. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Santhanam, D. W. Christianson, D. Nyhan, and D. E. Berkowitz Arginase and vascular aging J Appl Physiol, November 1, 2008; 105(5): 1632 - 1642. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. F. Mitchell Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage J Appl Physiol, November 1, 2008; 105(5): 1652 - 1660. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Allison, J. E. Manson, R. D. Langer, A. Aragaki, S. Smoller, C. E. Lewis, A. Thomas, W. Lawson, B. B. Cochrane, J. Hsia, et al. Association Between Different Measures of Blood Pressure and Coronary Artery Calcium in Postmenopausal Women Hypertension, November 1, 2008; 52(5): 833 - 840. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Fu, W. Vongpatanasin, and B. D. Levine Neural and Nonneural Mechanisms for Sex Differences in Elderly Hypertension: Can Exercise Training Help? Hypertension, November 1, 2008; 52(5): 787 - 794. [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Rohrscheib, O. B. Myers, K. S. Servilla, C. D. Adams, D. Miskulin, E. J. Bedrick, W. C. Hunt, D. E. Lindsey, D. Gabaldon, P. G. Zager, et al. Age-related Blood Pressure Patterns and Blood Pressure Variability among Hemodialysis Patients Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1407 - 1414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Suwazono, M. Dochi, K. Sakata, Y. Okubo, M. Oishi, K. Tanaka, E. Kobayashi, and K. Nogawa Shift Work Is a Risk Factor for Increased Blood Pressure in Japanese Men: A 14-Year Historical Cohort Study Hypertension, September 1, 2008; 52(3): 581 - 586. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Flaa, I. K. Eide, S. E. Kjeldsen, and M. Rostrup Sympathoadrenal Stress Reactivity Is a Predictor of Future Blood Pressure: An 18-Year Follow-Up Study Hypertension, August 1, 2008; 52(2): 336 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Zheng, Z. Sun, J. Li, R. Zhang, X. Zhang, S. Liu, J. Li, C. Xu, D. Hu, and Y. Sun Pulse Pressure and Mean Arterial Pressure in Relation to Ischemic Stroke Among Patients With Uncontrolled Hypertension in Rural Areas of China Stroke, July 1, 2008; 39(7): 1932 - 1937. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Najjar, A. Scuteri, V. Shetty, J. G. Wright, D. C. Muller, J. L. Fleg, H. P. Spurgeon, L. Ferrucci, and E. G. Lakatta Pulse Wave Velocity Is an Independent Predictor of the Longitudinal Increase in Systolic Blood Pressure and of Incident Hypertension in the Baltimore Longitudinal Study of Aging J. Am. Coll. Cardiol., April 8, 2008; 51(14): 1377 - 1383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Schaeffner, T. Kurth, T. S. Bowman, R. P. Gelber, and J. M. Gaziano Blood pressure measures and risk of chronic kidney disease in men Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1246 - 1251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Delahousse, M. Chaignon, L. Mesnard, P. Boutouyrie, M. E. Safar, T. Lebret, M. Pastural-Thaunat, L. Tricot, A. Kolko-Labadens, A. Karras, et al. Aortic Stiffness of Kidney Transplant Recipients Correlates with Donor Age J. Am. Soc. Nephrol., April 1, 2008; 19(4): 798 - 805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Dart, B. A. Kingwell, C. D. Gatzka, K. Willson, Y.-L. Liang, K. L. Berry, L. M.H. Wing, C. M. Reid, P. Ryan, L. J. Beilin, et al. Smaller Aortic Dimensions Do Not Fully Account for the Greater Pulse Pressure in Elderly Female Hypertensives Hypertension, April 1, 2008; 51(4): 1129 - 1134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. F. Mitchell, V. Gudnason, L. J. Launer, T. Aspelund, and T. B. Harris Hemodynamics of Increased Pulse Pressure in Older Women in the Community-Based Age, Gene/Environment Susceptibility-Reykjavik Study Hypertension, April 1, 2008; 51(4): 1123 - 1128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Hadji Menopausal symptoms and adjuvant therapy-associated adverse events Endocr. Relat. Cancer, March 1, 2008; 15(1): 73 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Safar Review: Pulse pressure, arterial stiffness and wave reflections (augmentation index) as cardiovascular risk factors in hypertension Therapeutic Advances in Cardiovascular Disease, February 1, 2008; 2(1): 13 - 24. [Abstract] [PDF]
|
|
|
|
|
|
S. M. Farasat, C. H. Morrell, A. Scuteri, C.-T. Ting, F. C.P. Yin, H. A. Spurgeon, C.-H. Chen, E. G. Lakatta, and S. S. Najjar Pulse Pressure Is Inversely Related to Aortic Root Diameter Implications for the Pathogenesis of Systolic Hypertension Hypertension, February 1, 2008; 51(2): 196 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. I. Parikh, M. J. Pencina, T. J. Wang, E. J. Benjamin, K. J. Lanier, D. Levy, R. B. D'Agostino Sr, W. B. Kannel, and R. S. Vasan A Risk Score for Predicting Near-Term Incidence of Hypertension: The Framingham Heart Study Ann Intern Med, January 15, 2008; 148(2): 102 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Liu, W. Zhang, and G. S. Kassab Effects of myocardial constraint on the passive mechanical behaviors of the coronary vessel wall Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H514 - H523. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Nilsson High-normal blood pressure and future risks a new concern for clinicians? Eur. Heart J., December 1, 2007; 28(23): 2832 - 2833. [Full Text] [PDF]
|
|
|
|
|
|
G. Michelson, J. Harazny, R. E. Schmieder, R. Berendes, T. Fiermann, and S. Warntges Fourier Analysis of the Envelope of the Ophthalmic Artery Blood Flow Velocity: Age- and Blood Pressure Related Impact Hypertension, November 1, 2007; 50(5): 964 - 969. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Benjo, R. E. Thompson, D. Fine, C. W. Hogue, D. Alejo, A. Kaw, G. Gerstenblith, A. Shah, D. E. Berkowitz, and D. Nyhan Pulse Pressure Is an Age-Independent Predictor of Stroke Development After Cardiac Surgery Hypertension, October 1, 2007; 50(4): 630 - 635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jacobson, C. Yan, Q. Gao, T. Rincon-Skinner, A. Rivera, J. Edwards, A. Huang, G. Kaley, and D. Sun Aging enhances pressure-induced arterial superoxide formation Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1344 - H1350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Zintzaras, G. Kitsios, D. Kent, N. J. Camp, L. Atwood, P. N. Hopkins, and S. C. Hunt Genome-Wide Scans Meta-Analysis for Pulse Pressure Hypertension, September 1, 2007; 50(3): 557 - 564. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. V. Chobanian Isolated Systolic Hypertension in the Elderly N. Engl. J. Med., August 23, 2007; 357(8): 789 - 796. [Full Text] [PDF]
|
|
|
|
|
|
C. Rosendorff, H. R. Black, C. P. Cannon, B. J. Gersh, J. Gore, J. L. Izzo Jr, N. M. Kaplan, C. M. O'Connor, P. T. O'Gara, and S. Oparil REPRINT Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention Hypertension, August 1, 2007; 50(2): e28 - e55. [Full Text] [PDF]
|
|
|
|
|
|
M. F. O'Rourke and J. Hashimoto Mechanical Factors in Arterial Aging: A Clinical Perspective J. Am. Coll. Cardiol., July 3, 2007; 50(1): 1 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Fantin, A. Mattocks, C. J. Bulpitt, W. Banya, and C. Rajkumar Reply Age Ageing, July 1, 2007; 36(4): 476 - 476. [Full Text] [PDF]
|
|
|
|
|
|
Authors/Task Force Members:, G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, G. Germano, G. Grassi, A. M. Heagerty, S. E. Kjeldsen, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur. Heart J., June 11, 2007; (2007) ehm236v1. [Full Text] [PDF]
|
|
|
|
|
|
W. J. Mosley II, P. Greenland, D. B. Garside, and D. M. Lloyd-Jones Predictive Utility of Pulse Pressure and Other Blood Pressure Measures for Cardiovascular Outcomes Hypertension, June 1, 2007; 49(6): 1256 - 1264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Mancia, M. Bombelli, R. Facchetti, F. Madotto, G. Corrao, F. Q. Trevano, G. Grassi, and R. Sega Long-Term Prognostic Value of Blood Pressure Variability in the General Population: Results of the Pressioni Arteriose Monitorate e Loro Associazioni Study Hypertension, June 1, 2007; 49(6): 1265 - 1270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Rosendorff, H. R. Black, C. P. Cannon, B. J. Gersh, J. Gore, J. L. Izzo Jr, N. M. Kaplan, C. M. O'Connor, P. T. O'Gara, and S. Oparil Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention Circulation, May 29, 2007; 115(21): 2761 - 2788. [Full Text] [PDF]
|
|
|
|
 |
|
 H T Ong beta blockers in hypertension and cardiovascular disease BMJ, May 5, 2007; 334(7600): 946 - 949. [Full Text] [PDF]
|
|
|
|
|
|
J. Cameron Ageing and central aortic pulse wave analysis. Commentary on 'Is Augmentation Index a Good Measure of Vascular Stiffness in the Elderly?' by Fantin et al. Age Ageing, January 1, 2007; 36(1): 3 - 5. [Full Text] [PDF]
|
|
|
|
|
|
G. Fernandez-Fresnedo, E. Rodrigo, A. L. M. de Francisco, S. S. de Castro, O. Castaneda, and M. Arias Role of Pulse Pressure on Cardiovascular Risk in Chronic Kidney Disease Patients J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S246 - S249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Perez Appraising Adjuvant Aromatase Inhibitor Therapy Oncologist, November 1, 2006; 11(10): 1058 - 1069. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. van Bemmel, K. Woittiez, G. J. Blauw, F. van der Sman-de Beer, F. W. Dekker, R. G.J. Westendorp, and J. Gussekloo Prospective Study of the Effect of Blood Pressure on Renal Function in Old Age: The Leiden 85-Plus Study J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2561 - 2566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Kaufmann, L. M. Bachmann, Y. C. Robert, and M. A. Thiel Ocular Pulse Amplitude in Healthy Subjects as Measured by Dynamic Contour Tonometry. Arch Ophthalmol, August 1, 2006; 124(8): 1104 - 1108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. O'Rourke and J. B. Seward Central Arterial Pressure and Arterial Pressure Pulse: New Views Entering the Second Century After Korotkov Mayo Clin. Proc., August 1, 2006; 81(8): 1057 - 1068. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Khan and F. A. McAlister Re-examining the efficacy of {beta}-blockers for the treatment of hypertension: a meta-analysis Can. Med. Assoc. J., June 6, 2006; 174(12): 1737 - 1742. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tsakiris, M. Doumas, D. Lagatouras, G. Vyssoulis, E. Karpanou, N. Nearchou, C. Kouremenou, and P. Skoufas Microalbuminuria Is Determined by Systolic and Pulse Pressure Over a 12-Year Period and Related to Peripheral Artery Disease in Normotensive and Hypertensive Subjects: The Three Areas Study in Greece (TAS-GR) Angiology, May 1, 2006; 57(3): 313 - 320. [Abstract] [PDF]
|
|
|
|
 |
|
 C. M. Masi, L. C. Hawkley, J. D. Berry, and J. T. Cacioppo Estrogen Metabolites and Systolic Blood Pressure in a Population-Based Sample of Postmenopausal Women J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1015 - 1020. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Li, J.-G. Wang, E. Dolan, P.-J. Gao, H.-F. Guo, T. Nawrot, A. V. Stanton, D.-L. Zhu, E. O'Brien, and J. A. Staessen Ambulatory Arterial Stiffness Index Derived From 24-Hour Ambulatory Blood Pressure Monitoring Hypertension, March 1, 2006; 47(3): 359 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Dolan, L. Thijs, Y. Li, N. Atkins, P. McCormack, S. McClory, E. O'Brien, J. A. Staessen, and A. V. Stanton Ambulatory Arterial Stiffness Index as a Predictor of Cardiovascular Mortality in the Dublin Outcome Study Hypertension, March 1, 2006; 47(3): 365 - 370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Schulman, L. C. Becker, D. A. Kass, H. C. Champion, M. L. Terrin, S. Forman, K. V. Ernst, M. D. Kelemen, S. N. Townsend, A. Capriotti, et al. L-Arginine Therapy in Acute Myocardial Infarction: The Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) Randomized Clinical Trial JAMA, January 4, 2006; 295(1): 58 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Freitag, R. Peila, K. Masaki, H. Petrovitch, G. W. Ross, L. R. White, and L. J. Launer Midlife Pulse Pressure and Incidence of Dementia: The Honolulu-Asia Aging Study Stroke, January 1, 2006; 37(1): 33 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. McEniery, Yasmin, I. R. Hall, A. Qasem, I. B. Wilkinson, J. R. Cockcroft, and on behalf of the ACCT Investigators Normal Vascular Aging: Differential Effects on Wave Reflection and Aortic Pulse Wave Velocity: The Anglo-Cardiff Collaborative Trial (ACCT) J. Am. Coll. Cardiol., November 1, 2005; 46(9): 1753 - 1760. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Natoli, T. L. Medley, A. A. Ahimastos, B. G. Drew, D. J. Thearle, R. J. Dilley, and B. A. Kingwell Sex Steroids Modulate Human Aortic Smooth Muscle Cell Matrix Protein Deposition and Matrix Metalloproteinase Expression Hypertension, November 1, 2005; 46(5): 1129 - 1134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Redfield, S. J. Jacobsen, B. A. Borlaug, R. J. Rodeheffer, and D. A. Kass Age- and Gender-Related Ventricular-Vascular Stiffening: A Community-Based Study Circulation, October 11, 2005; 112(15): 2254 - 2262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Assmann, P. Cullen, T. Evers, D. Petzinna, and H. Schulte Importance of arterial pulse pressure as a predictor of coronary heart disease risk in PROCAM Eur. Heart J., October 2, 2005; 26(20): 2120 - 2126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Seubert, F. Xu, J. P. Graves, J. B. Collins, S. O. Sieber, R. S. Paules, D. L. Kroetz, and D. C. Zeldin Differential renal gene expression in prehypertensive and hypertensive spontaneously hypertensive rats Am J Physiol Renal Physiol, September 1, 2005; 289(3): F552 - F561. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Najjar, A. Scuteri, and E. G. Lakatta Arterial Aging: Is It an Immutable Cardiovascular Risk Factor? Hypertension, September 1, 2005; 46(3): 454 - 462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Benetos Does Blood Pressure Control Contribute to a More Successful Aging? Hypertension, August 1, 2005; 46(2): 261 - 262. [Full Text] [PDF]
|
|
|
|
|
|
M. Zureik, P. Galan, S. Bertrais, D. Courbon, S. Czernichow, J. Blacher, P. Ducimetiere, M. E. Safar, and S. Hercberg Parental Longevity and 7-Year Changes in Blood Pressures in Adult Offspring Hypertension, August 1, 2005; 46(2): 287 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Lloyd-Jones, J. C. Evans, and D. Levy Hypertension in Adults Across the Age Spectrum: Current Outcomes and Control in the Community JAMA, July 27, 2005; 294(4): 466 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Schram, C. G. Schalkwijk, A. H. Bootsma, J. H. Fuller, N. Chaturvedi, C. D.A. Stehouwer, and on behalf of the EURODIAB Prospective Complication Advanced Glycation End Products Are Associated With Pulse Pressure in Type 1 Diabetes: The EURODIAB Prospective Complications Study Hypertension, July 1, 2005; 46(1): 232 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. O'Rourke and M. E. Safar Relationship Between Aortic Stiffening and Microvascular Disease in Brain and Kidney: Cause and Logic of Therapy Hypertension, July 1, 2005; 46(1): 200 - 204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. McEniery, Yasmin, S. Wallace, K. Maki-Petaja, B. McDonnell, J. E. Sharman, C. Retallick, S. S. Franklin, M. J. Brown, R. C. Lloyd, et al. Increased Stroke Volume and Aortic Stiffness Contribute to Isolated Systolic Hypertension in Young Adults Hypertension, July 1, 2005; 46(1): 221 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-G. Wang, J. A. Staessen, S. S. Franklin, R. Fagard, and F. Gueyffier Systolic and Diastolic Blood Pressure Lowering as Determinants of Cardiovascular Outcome Hypertension, May 1, 2005; 45(5): 907 - 913. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Verhave, P. Fesler, G. du Cailar, J. Ribstein, M. E. Safar, and A. Mimran Elevated Pulse Pressure Is Associated With Low Renal Function in Elderly Patients With Isolated Systolic Hypertension Hypertension, April 1, 2005; 45(4): 586 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. O'Rourke and W. W. Nichols Aortic Diameter, Aortic Stiffness, and Wave Reflection Increase With Age and Isolated Systolic Hypertension Hypertension, April 1, 2005; 45(4): 652 - 658. [Full Text] [PDF]
|
|
|
|
|
|
P. Verdecchia and F. Angeli Natural History of Hypertension Subtypes Circulation, March 8, 2005; 111(9): 1094 - 1096. [Full Text] [PDF]
|
|
|
|
|
|
S. S. Franklin, J. R. Pio, N. D. Wong, M. G. Larson, E. P. Leip, R. S. Vasan, and D. Levy Predictors of New-Onset Diastolic and Systolic Hypertension: The Framingham Heart Study Circulation, March 8, 2005; 111(9): 1121 - 1127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Franklin Arterial Stiffness and Hypertension: A Two-Way Street? Hypertension, March 1, 2005; 45(3): 349 - 351. [Full Text] [PDF]
|
|
|
|
|
|
D. C. Haas, G. L. Foster, F. J. Nieto, S. Redline, H. E. Resnick, J. A. Robbins, T. Young, and T. G. Pickering Age-Dependent Associations Between Sleep-Disordered Breathing and Hypertension: Importance of Discriminating Between Systolic/Diastolic Hypertension and Isolated Systolic Hypertension in the Sleep Heart Health Study Circulation, February 8, 2005; 111(5): 614 - 621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W.J. Vriend, A. H. Zwinderman, E. de Groot, J. J.P. Kastelein, B. J. Bouma, and B. J.M. Mulder Predictive value of mild, residual descending aortic narrowing for blood pressure and vascular damage in patients after repair of aortic coarctation Eur. Heart J., January 1, 2005; 26(1): 84 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nakano, K. Konishi, K. Furuya, K. Uehara, M. Nishizawa, A. Nakagawa, T. Kigoshi, and K. Uchida A Prognostic Role of Mean 24-h Pulse Pressure Level for Cardiovascular Events in Type 2 Diabetic Subjects Under 60 Years of Age Diabetes Care, January 1, 2005; 28(1): 95 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Miura, Y. Soyama, Y. Morikawa, M. Nishijo, Y. Nakanishi, Y. Naruse, K. Yoshita, S. Kagamimori, and H. Nakagawa Comparison of Four Blood Pressure Indexes for the Prediction of 10-Year Stroke Risk in Middle-Aged and Older Asians Hypertension, November 1, 2004; 44(5): 715 - 720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ronnback, J. Fagerudd, C. Forsblom, K. Pettersson-Fernholm, A. Reunanen, P.-H. Groop, and on behalf of the Finnish Diabetic Nephropathy Stu Altered Age-Related Blood Pressure Pattern in Type 1 Diabetes Circulation, August 31, 2004; 110(9): 1076 - 1082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Najjar, S. P. Schulman, G. Gerstenblith, J. L. Fleg, D. A. Kass, F. O'Connor, L. C. Becker, and E. G. Lakatta Age and gender affect ventricular-vascular coupling during aerobic exercise J. Am. Coll. Cardiol., August 4, 2004; 44(3): 611 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N. Cohn, A. A. Quyyumi, N. K. Hollenberg, and K. A. Jamerson Surrogate Markers for Cardiovascular Disease: Functional Markers Circulation, June 29, 2004; 109(25_suppl_1): IV-31 - IV-46. [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Pauca, N. D. Kon, and M. F. O'Rourke The second peak of the radial artery pressure wave represents aortic systolic pressure in hypertensive and elderly patients Br. J. Anaesth., May 1, 2004; 92(5): 651 - 657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Yasmin, C. M. McEniery, S. Wallace, I. S. Mackenzie, J. R. Cockcroft, and I. B. Wilkinson C-Reactive Protein Is Associated With Arterial Stiffness in Apparently Healthy Individuals Arterioscler. Thromb. Vasc. Biol., May 1, 2004; 24(5): 969 - 974. [Abstract] [Full Text]
|
|
|
|
|
|
A. M. Dart, C. D. Gatzka, J. D. Cameron, B. A. Kingwell, Y.-L. Liang, K. L. Berry, C. M. Reid, and G. L. Jennings Large Artery Stiffness Is Not Related to Plasma Cholesterol in Older Subjects with Hypertension Arterioscler. Thromb. Vasc. Biol., May 1, 2004; 24(5): 962 - 968. [Abstract] [Full Text]
|
|
|
|
|
|
P. J. Mason, J. E. Manson, H. D. Sesso, C. M. Albert, M. J. Chown, N. R. Cook, P. Greenland, P. M Ridker, and R. J. Glynn Blood Pressure and Risk of Secondary Cardiovascular Events in Women: The Women's Antioxidant Cardiovascular Study (WACS) Circulation, April 6, 2004; 109(13): 1623 - 1629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Howell, J. W. Sear, and P. Foex Hypertension, hypertensive heart disease and perioperative cardiac risk{dagger} Br. J. Anaesth., April 1, 2004; 92(4): 570 - 583. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Safar, M. Lajemi, A. Rudnichi, R. Asmar, and A. Benetos Angiotensin-Converting Enzyme D/I Gene Polymorphism and Age-Related Changes in Pulse Pressure in Subjects with Hypertension Arterioscler. Thromb. Vasc. Biol., April 1, 2004; 24(4): 782 - 786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. F. Mitchell Increased Aortic Stiffness: An Unfavorable Cardiorenal Connection Hypertension, February 1, 2004; 43(2): 151 - 153. [Full Text] [PDF]
|
|
|
|
|
|
A. V. Chobanian, G. L. Bakris, H. R. Black, W. C. Cushman, L. A. Green, J. L. Izzo Jr, D. W. Jones, B. J. Materson, S. Oparil, J. T. Wright Jr, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension, December 1, 2003; 42(6): 1206 - 1252. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Oliveira-Filho, S.C.S. Silva, C.C. Trabuco, B.B. Pedreira, E.U. Sousa, and A. Bacellar Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset Neurology, October 28, 2003; 61(8): 1047 - 1051. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Safar and P. Laurent Pulse pressure and arterial stiffness in rats: comparison with humans Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1363 - H1369. [Full Text] [PDF]
|
|
|
|
 |
|
 O. O. Aalami, T. D. Fang, H. M. Song, and R. P. Nacamuli Physiological Features of Aging Persons Arch Surg, October 1, 2003; 138(10): 1068 - 1076. [Full Text] [PDF]
|
|
|
|
|
|
C. Qiu, B. Winblad, J. Fastbom, and L. Fratiglioni Combined effects of APOE genotype, blood pressure, and antihypertensive drug use on incident AD Neurology, September 9, 2003; 61(5): 655 - 660. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Futterman and L. Lemberg The Effects of Aging on Arteries Am. J. Crit. Care., September 1, 2003; 12(5): 472 - 475. [Full Text] [PDF]
|
|
|
|
|
|
N. J. Camp, P. N. Hopkins, S. J. Hasstedt, H. Coon, A. Malhotra, R. M. Cawthon, and S. C. Hunt Genome-Wide Multipoint Parametric Linkage Analysis of Pulse Pressure in Large, Extended Utah Pedigrees Hypertension, September 1, 2003; 42(3): 322 - 328. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||